| ■ 영문 제목 : Global Mycoplasma Hyopneumoniae Vaccine Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02100 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 100 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 마이코플라즈마 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (라이브, 비활성화)와 용도별 시장규모 (새끼 돼지, 성체 돼지) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 마이코플라즈마 백신 시장 점유율 - 지역별 마이코플라즈마 백신 시장규모 - 주요지역의 종류별 시장규모 (라이브, 비활성화) - 주요지역의 용도별 시장규모 (새끼 돼지, 성체 돼지) - 미주의 마이코플라즈마 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 마이코플라즈마 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 마이코플라즈마 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 마이코플라즈마 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 마이코플라즈마 백신 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Zoetis, Merck, Boehringer Ingelheim, Ceva Santé Animale, Elanco Animal Health, Qilu Animal Health, Ruipu, Shanghai Hile Bio-Technology Co., Ltd., CAHIC, Pulike, Harbin Pharmaceutical Group - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Mycoplasma Hyopneumoniae Vaccine will have significant change from previous year. By the most conservative estimates of global Mycoplasma Hyopneumoniae Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Mycoplasma Hyopneumoniae Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Mycoplasma Hyopneumoniae Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Live
Inactivated
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Piglets
Adult Pigs
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Zoetis
Merck
Boehringer Ingelheim
Ceva Santé Animale
Elanco Animal Health
Qilu Animal Health
Ruipu
Shanghai Hile Bio-Technology Co., Ltd.
CAHIC
Pulike
Harbin Pharmaceutical Group
1 Scope of the Report 2 Executive Summary 3 Global Mycoplasma Hyopneumoniae Vaccine by Company 4 Mycoplasma Hyopneumoniae Vaccine by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Mycoplasma Hyopneumoniae Vaccine Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Mycoplasma Hyopneumoniae Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Live Table 3. Major Players of Inactivated Table 4. Global Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units) Table 5. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021) Table 6. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2016-2021) & ($ million) Table 7. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2016-2021) Table 8. Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Type (2016-2021) Table 9. Global Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units) Table 10. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021) Table 11. Global Mycoplasma Hyopneumoniae Vaccine Value by Application (2016-2021) Table 12. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2016-2021) Table 13. Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Application (2016-2021) Table 14. Global Mycoplasma Hyopneumoniae Vaccine Sales by Company (2019-2021) & (K Units) Table 15. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Company (2019-2021) Table 16. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Company (2019-2021) ($ Millions) Table 17. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company (2019-2021) Table 18. Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Company (2019-2021) Table 19. Key Manufacturers Mycoplasma Hyopneumoniae Vaccine Producing Area Distribution and Sales Area Table 20. Players Mycoplasma Hyopneumoniae Vaccine Products Offered Table 21. Mycoplasma Hyopneumoniae Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Mycoplasma Hyopneumoniae Vaccine Sales by Region (2016-2021) (K Units) Table 25. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2016-2021) Table 26. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2016-2021) Table 28. Americas Mycoplasma Hyopneumoniae Vaccine Sales by Country (2016-2021) & (K Units) Table 29. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2016-2021) Table 30. Americas Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2016-2021) Table 32. Americas Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units) Table 33. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021) Table 34. Americas Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units) Table 35. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021) Table 36. APAC Mycoplasma Hyopneumoniae Vaccine Sales by Region (2016-2021) & (K Units) Table 37. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2016-2021) Table 38. APAC Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2016-2021) Table 40. APAC Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units) Table 41. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021) Table 42. APAC Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units) Table 43. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021) Table 44. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Country (2016-2021) & (K Units) Table 45. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2016-2021) Table 46. Europe Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2016-2021) Table 48. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units) Table 49. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021) Table 50. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units) Table 51. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Country (2016-2021) & (K Units) Table 53. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units) Table 57. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units) Table 59. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Mycoplasma Hyopneumoniae Vaccine Table 61. Key Application and Potential Industries of Mycoplasma Hyopneumoniae Vaccine Table 62. Key Challenges of Mycoplasma Hyopneumoniae Vaccine Table 63. Key Trends of Mycoplasma Hyopneumoniae Vaccine Table 64. Mycoplasma Hyopneumoniae Vaccine Distributors List Table 65. Mycoplasma Hyopneumoniae Vaccine Customer List Table 66. Global Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Region (2021-2026) & (K Units) Table 67. Global Mycoplasma Hyopneumoniae Vaccine Consumption Market Forecast by Region Table 68. Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2021-2026) & (K Units) Table 71. Americas Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Region (2021-2026) & (K Units) Table 73. APAC Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2021-2026) & (K Units) Table 75. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2021-2026) & (K Units) Table 77. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Type (2021-2026) & (K Units) Table 79. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Type (2021-2026) Table 80. Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Application (2021-2026) & (K Units) Table 83. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Application (2021-2026) Table 84. Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share Forecast by Application (2021-2026) Table 86. Zoetis Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 87. Zoetis Mycoplasma Hyopneumoniae Vaccine Product Offered Table 88. Zoetis Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 89. Zoetis Main Business Table 90. Zoetis Latest Developments Table 91. Merck Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 92. Merck Mycoplasma Hyopneumoniae Vaccine Product Offered Table 93. Merck Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 94. Merck Main Business Table 95. Merck Latest Developments Table 96. Boehringer Ingelheim Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 97. Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Product Offered Table 98. Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 99. Boehringer Ingelheim Main Business Table 100. Boehringer Ingelheim Latest Developments Table 101. Ceva Santé Animale Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 102. Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Product Offered Table 103. Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 104. Ceva Santé Animale Main Business Table 105. Ceva Santé Animale Latest Developments Table 106. Elanco Animal Health Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 107. Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered Table 108. Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 109. Elanco Animal Health Main Business Table 110. Elanco Animal Health Latest Developments Table 111. Qilu Animal Health Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 112. Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered Table 113. Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 114. Qilu Animal Health Main Business Table 115. Qilu Animal Health Latest Developments Table 116. Ruipu Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 117. Ruipu Mycoplasma Hyopneumoniae Vaccine Product Offered Table 118. Ruipu Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 119. Ruipu Main Business Table 120. Ruipu Latest Developments Table 121. Shanghai Hile Bio-Technology Co., Ltd. Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 122. Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Product Offered Table 123. Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 124. Shanghai Hile Bio-Technology Co., Ltd. Main Business Table 125. Shanghai Hile Bio-Technology Co., Ltd. Latest Developments Table 126. CAHIC Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 127. CAHIC Mycoplasma Hyopneumoniae Vaccine Product Offered Table 128. CAHIC Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 129. CAHIC Main Business Table 130. CAHIC Latest Developments Table 131. Pulike Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 132. Pulike Mycoplasma Hyopneumoniae Vaccine Product Offered Table 133. Pulike Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 134. Pulike Main Business Table 135. Pulike Latest Developments Table 136. Harbin Pharmaceutical Group Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 137. Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Product Offered Table 138. Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 139. Harbin Pharmaceutical Group Main Business Table 140. Harbin Pharmaceutical Group Latest Developments List of Figures Figure 1. Picture of Mycoplasma Hyopneumoniae Vaccine Figure 2. Mycoplasma Hyopneumoniae Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Mycoplasma Hyopneumoniae Vaccine Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Live Figure 10. Product Picture of Inactivated Figure 11. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020 Figure 12. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2016-2021) Figure 13. Mycoplasma Hyopneumoniae Vaccine Consumed in Piglets Figure 14. Global Mycoplasma Hyopneumoniae Vaccine Market: Piglets (2016-2021) & (K Units) Figure 15. Mycoplasma Hyopneumoniae Vaccine Consumed in Adult Pigs Figure 16. Global Mycoplasma Hyopneumoniae Vaccine Market: Adult Pigs (2016-2021) & (K Units) Figure 17. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021) Figure 18. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application in 2020 Figure 19. Mycoplasma Hyopneumoniae Vaccine Revenue Market by Company in 2020 ($ Million) Figure 20. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company in 2020 Figure 21. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Regions (2016-2021) Figure 22. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region in 2020 Figure 23. Americas Mycoplasma Hyopneumoniae Vaccine Sales 2016-2021 (K Units) Figure 24. Americas Mycoplasma Hyopneumoniae Vaccine Revenue 2016-2021 ($ Millions) Figure 25. APAC Mycoplasma Hyopneumoniae Vaccine Sales 2016-2021 (K Units) Figure 26. APAC Mycoplasma Hyopneumoniae Vaccine Revenue 2016-2021 ($ Millions) Figure 27. Europe Mycoplasma Hyopneumoniae Vaccine Sales 2016-2021 (K Units) Figure 28. Europe Mycoplasma Hyopneumoniae Vaccine Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales 2016-2021 (K Units) Figure 30. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue 2016-2021 ($ Millions) Figure 31. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country in 2020 Figure 32. Americas Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country in 2020 Figure 33. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020 Figure 34. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application in 2020 Figure 35. United States Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region in 2020 Figure 40. APAC Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Regions in 2020 Figure 41. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020 Figure 42. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application in 2020 Figure 43. China Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 47. India Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country in 2020 Figure 50. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country in 2020 Figure 51. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020 Figure 52. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application in 2020 Figure 53. Germany Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 54. France Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application in 2020 Figure 62. Egypt Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 마이코플라즈마 백신 시장예측 2021년-2026년] (코드 : LPI-2201K02100) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 마이코플라즈마 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |